235 related articles for article (PubMed ID: 2148480)
1. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
Hanasaki K; Nakano T; Arita H
Biochem Pharmacol; 1990 Dec; 40(11):2535-42. PubMed ID: 2148480
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
3. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
Hanasaki K; Nakano K; Kasai H; Arita H; Ohtani K; Doteuchi M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1170-5. PubMed ID: 2963633
[TBL] [Abstract][Full Text] [Related]
4. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
Dorn GW; Becker MW
J Pharmacol Exp Ther; 1993 Apr; 265(1):447-56. PubMed ID: 8474027
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
7. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux.
Dorn GW; Sens D; Chaikhouni A; Mais D; Halushka PV
Circ Res; 1987 Jun; 60(6):952-6. PubMed ID: 2954721
[TBL] [Abstract][Full Text] [Related]
8. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
9. Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells.
Masuda A; Mathur R; Halushka PV
Circ Res; 1991 Sep; 69(3):638-43. PubMed ID: 1831411
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 and vascular smooth muscle cell proliferation.
Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H
Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
[TBL] [Abstract][Full Text] [Related]
11. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Miki I; Kase H; Ishii A
Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells.
Hanasaki K; Nakano K; Kasai H; Arita H
Biochem Pharmacol; 1989 Sep; 38(18):2967-76. PubMed ID: 2528958
[TBL] [Abstract][Full Text] [Related]
13. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
Shams G; Wallace LJ; Miller DD; Feller DR
Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]